Navigation Links
GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Date:12/11/2008

ler medicine. People should speak to their doctor about the risks and benefits of treating their asthma with Advair Diskus. People taking Advair Diskus should see their doctor if their asthma does not improve. People should tell their doctor if they have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate, or changes in heart rhythm. Advair Diskus is for patients 4 years and older. For patients 4 to 11 years old, Advair Diskus 100/50 is for those who have asthma symptoms while on an inhaled corticosteroid.

Important information about Serevent Diskus

Serevent Diskus is indicated for the maintenance treatment of asthma in patients 4 years of age and older. Serevent Diskus does not replace fast-acting inhalers for sudden symptoms and should not be taken more than twice a day. In patients with asthma, medicines like Serevent may increase the chance of asthma-related death. People should talk to their doctor about this risk and the benefits of treating their asthma with Serevent Diskus. Serevent Diskus should not be the only controller medicine prescribed for a person's asthma and is not a substitute for anti-inflammatory medications (inhaled or oral corticosteroids). People should tell their doctor if they have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate, or changes in heart rhythm. People should see their doctor if their asthma does not improve.

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
2. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
3. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
4. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
5. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
6. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
7. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
8. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
9. IADR and GlaxoSmithKline Consumer Healthcare announce winners
10. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
11. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... 2015 , ... Western University of Health Sciences’ newest class ... growing percentage of U.S. physicians, and reflects the diversity of the communities where ... message delivered by John W. Becher, DO, president of the American Osteopathic Association, ...
(Date:8/1/2015)... CA (PRWEB) , ... August 01, 2015 , ... Have you ever wondered what “Karma” ... when you hear the word “Karma.” , Vedic tradition, which gave birth to Hinduism, ... is one of the central concepts of this tradition. According to the wisdom of this ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are enlarged ... women often causing pain and discomfort. Those who spend a lot of time on ... Houston Vein Center is doing what it can to create awareness and provide a ...
(Date:8/1/2015)... ... ... Calvary Hospital today announced that it is embarking on a yearlong restoration ... bring this Torah – dating from 1880 – back to kosher status, so that ... Scroll No. 515, from the town of Taus-Domazlice, is on permanent loan to Calvary ...
(Date:8/1/2015)... Freeport, ME (PRWEB) , ... August 01, 2015 , ... ... “America’s Retail Champions.” , Wilcoxson was given that honor by the National Retail Federation, ... the retail industry. Wilcoxson was one of three Maine business owners to be named ...
Breaking Medicine News(10 mins):Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Local Retail Advocate Wins National Recognition 2
... ST. PAUL, Minn., Sept. 10 . Two heroes of ... New York,s Hudson River last January will visit the Twin Cities ... fundraiser. , , Patrick Harten , the ... choose an emergency response, and cool-headed flight attendant Doreen Welsh ...
... MALVERN, Pa., Sept. 10 Ascenta Therapeutics announced today that following ... its Investigational New Drug (IND) Application for AT-406, an orally-active, small ... trial in patients with advanced cancer during the fourth quarter of ... ) , , "We are very pleased ...
... TORONTO, Sept. 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... the global life sciences markets, today reported financial results for the ... $199 million, a net loss of $62 million and a loss ... with $252 million in total revenue, a net loss of $10 ...
... , ARMONK, N.Y., Sept. 10 ... (CIOs), released by IBM (NYSE: IBM ) today, ... business decision-making is now the top priority for CIOs. More than ... and analytics - the ability to see patterns in vast amounts ...
... , , LONG BEACH, Calif., Sept. 10 ... this system is you. All I ask in return for using my system ... said Bob Ainuu Afamasaga. , , "Millions of Europeans ... mind because, as I have already said several times, creating debt is no solution..." ...
... ... Shepherd presented at this year,s Pennsylvania Association for Justice (PaAJ) "Pennsylvania Master Series, ... , ... PA (PRWEB) September 10, 2009 -- Feldman, Shepherd, Wohlgelernter, Tanner, Weinstock & Dodig ...
Cached Medicine News:Health News:Wings of Mercy Benefit Features 'Miracle on the Hudson' Heroes 2Health News:Wings of Mercy Benefit Features 'Miracle on the Hudson' Heroes 3Health News:Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT-406 2Health News:MDS Reports Third Quarter 2009 Financial Results 2Health News:MDS Reports Third Quarter 2009 Financial Results 3Health News:MDS Reports Third Quarter 2009 Financial Results 4Health News:MDS Reports Third Quarter 2009 Financial Results 5Health News:MDS Reports Third Quarter 2009 Financial Results 6Health News:MDS Reports Third Quarter 2009 Financial Results 7Health News:MDS Reports Third Quarter 2009 Financial Results 8Health News:MDS Reports Third Quarter 2009 Financial Results 9Health News:MDS Reports Third Quarter 2009 Financial Results 10Health News:MDS Reports Third Quarter 2009 Financial Results 11Health News:MDS Reports Third Quarter 2009 Financial Results 12Health News:MDS Reports Third Quarter 2009 Financial Results 13Health News:MDS Reports Third Quarter 2009 Financial Results 14Health News:MDS Reports Third Quarter 2009 Financial Results 15Health News:MDS Reports Third Quarter 2009 Financial Results 16Health News:MDS Reports Third Quarter 2009 Financial Results 17Health News:MDS Reports Third Quarter 2009 Financial Results 18Health News:MDS Reports Third Quarter 2009 Financial Results 19Health News:MDS Reports Third Quarter 2009 Financial Results 20Health News:MDS Reports Third Quarter 2009 Financial Results 21Health News:MDS Reports Third Quarter 2009 Financial Results 22Health News:MDS Reports Third Quarter 2009 Financial Results 23Health News:New IBM Study Highlights Analytics as Top Priority for Today's CIO 2Health News:New IBM Study Highlights Analytics as Top Priority for Today's CIO 3Health News:New IBM Study Highlights Analytics as Top Priority for Today's CIO 4Health News:$0.00 Penny System to Jump Start Global Economy Developed by DNA and MIND Researcher. 2Health News:Philadelphia Attorney Carol Nelson Shepherd Presents at the 2009 Pennsylvania Association for Justice Master Series 2
(Date:7/31/2015)... , July 31, 2015  Physicians and payers ... the biopharmaceutical market. Patients are better informed and ... and switching therapies. This shift in power is ... efforts toward patient-focused marketing. As part ... have learned it,s important to educate, communicate and ...
(Date:7/31/2015)... CHAPEL HILL, N.C. , July 31, 2015 /PRNewswire/ ... needs of customers who are increasingly mobile, increasingly connected, ... support a growing variety of customer interaction channels and ... of technology, including social media. According ... of the over the counter (OTC) segment in a ...
(Date:7/31/2015)... YORK , July 31, 2015  Seeger Weiss LLP ... Administration (FDA) issued a warning letter to C.R. Bard, the ... not taking adequate strides to correct violations the agency found ... of these violations after the FDA cited them during Inspectional ... 2015, in Bard,s Tempe, AZ , location ...
Breaking Medicine Technology:Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3
... 2010 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... trial.  The Company has now completed the final trial necessary ... plans to submit an NDA in the first half of ... has completed Phase 3 clinical development for the acute treatment ...
... Inc. today announced $3 million in Convertible Note funding. ... Phase II trials of BPX-101, the company,s DeCIDe™ vaccine ... a cell therapy safety switch under initial development in ... The new funding brings the total raised to date ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 2MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 3Bellicum Pharmaceuticals Announces $3 Million in Convertible Note Funding 2
Round solid 15 mm wide lower plate. Open upper plate with inside diameter 12 mm. Serrated handle with locking thumb screw and polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
The popular E2002 Utrata Capsulorhexis Forceps with fine angled sharp tips. Angled 12 mm shafts with an iris stop. Flat handle with dull finish....
Fine angled tips ideal for grasping delicate capsule. Angled 12 mm shafts with iris stop allows ease of movement in the anterior chamber. Flat handle with dull finish. Manufactured in titanium....
Medicine Products: